Ultrasound Technology Enhancements Provide Imaging at Greater Depths

This significant improvement overcomes the difficultly associated with scanning larger and more technically challenging patients.

Esaote (Genoa, Italy), a world-leading developer of medical diagnostic systems, recently introduced CrystaLine range of ultrasound systems, a significant progression of its ultrasound technology that provides new degrees of accuracy, quality, flexibility, and cost-effectiveness.

CrystaLine integrates dedicated hardware and software features that build on the eHD ultrasound technology Esaote introduced in 2013. The higher quality and clearer imaging at increased depth now enables clinicians to effectively use ultrasound in borderline exams and interventional ultrasound procedures.

Carlos Faustmann, Esaote’s chief global marketing and domestic sales officer, clarified, “Ultrasound is highly valued for its safe, noninvasive nature, and continues to evolve and prove its value. One of the challenges has been capturing high quality images in those technically difficult patients. CrystaLine changes all that.”

Key technical enhancements provided by CrystaLine include combined pulse imaging technology, which effectively increases depth-of-field, improving the imaging of structures deeper in the body. Combined with the new XView+ speckle-noise reduction system, fully adjustable by the operator, helps to generate an enhanced customized image.

Esaote systems with CrystaLine are also able to synchronize in real-time with therapeutic applications such as Echolaser to guide laser ablation and other procedures. “CrystaLine enables clinicians to synchronize with interventional systems such as medical lasers,” continued Mr. Faustmann. “This feature plus the introduction of the 0° biopsy-interventional dedicated probe, is an example of the huge potential for Esaote and ultrasound in direct therapeutic applications.”

Esaote Group is a leading player in the biomedical equipment sector, with a specific focus on ultrasound, magnetic resonance, and software for managing the diagnostic process. Esaote has over 1,360 employees, 20% of which are employed in R&D activities.

Related Links:
Esaote